AnaptysBio (ANAB) Q1 2026 Earnings Report
MX:ANAB Q1 2026 EPS Results
- Actual EPS
- -MXN 15.85
- Consensus EPS
- MXN 6.45
- Beat/Miss
- Missed by -MXN 22.30
- One Year Ago EPS
- -MXN 23.84
MX:ANAB Q1 2026 Revenue Results
- Actual Revenue
- MXN 474.85M
- Expected Revenue
- MXN 1.42B
- Beat/Miss
- Missed by -MXN 943.24M
- YoY Revenue Growth
- -7.98%
Earnings Announcement Details
- Quarter
- Q1 2026
- Date
- 05/12/2026
- Time
- After Close
- Conference Call
- Tuesday, May 12, 2026
MX:ANAB Upcoming Earnings
AnaptysBio's next earnings date is estimated for November 10, 2026, based on past reporting schedules.
Q1 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q1 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q1 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:ANAB Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 10, 2026 | 2026 (Q3) | -34.19-34.19 | 9.68 | -453.17% (-43.87) | ― |
| Sep 21, 2026 | 2026 (Q2) | -16.59-16.59 | -16.59 | 0.00% (+0.00) | |
| May 12, 2026 | 2026 (Q1) | 6.45-15.85 | -23.84 | 33.52% (+7.99) | |
| Mar 03, 2026 | 2025 (Q4) | -16.5929.41 | -8.92 | 429.79% (+38.33) | |
| Nov 04, 2025 | 2025 (Q3) | -15.859.68 | -14.12 | 168.55% (+23.80) | |
| Aug 06, 2025 | 2025 (Q2) | -8.92-24.92 | -21.18 | -17.63% (-3.73) | |
| May 05, 2025 | 2025 (Q1) | -14.12-23.84 | -20.31 | -17.38% (-3.53) | |
| Feb 27, 2025 | 2024 (Q4) | -20.05-8.92 | -19.7 | 54.72% (+10.78) | |
| Nov 05, 2024 | 2024 (Q3) | -20.40-14.12 | -17.47 | 19.15% (+3.34) | |
| Aug 05, 2024 | 2024 (Q2) | -12.90-21.18 | -18.58 | -14.00% (-2.60) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
